Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIA Prostate Cancer”

257 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 257 results

Not applicableStudy completedNCT00416390
What this trial is testing

Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia

Who this might be right for
Nonmalignant NeoplasmProstate Cancer
University of Illinois at Chicago 120
Testing effectiveness (Phase 2)Ended earlyNCT00906243
What this trial is testing

RNActive®-Derived Therapeutic Vaccine

Who this might be right for
Hormone Refractory Prostate Cancer
University of Florida 6
Testing effectiveness (Phase 2)Ended earlyNCT01928485
What this trial is testing

Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer

Who this might be right for
Stage I Prostate CancerStage IIA Prostate CancerStage IIB Prostate Cancer
Sanjay Gupta PhD 6
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Large-scale testing (Phase 3)Study completedNCT00030654
What this trial is testing

Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 21
Testing effectiveness (Phase 2)Study completedNCT06472531
What this trial is testing

PET/CT Imaging Using INR101 Injection in Healthy Male Subjects and Patients With Suspected Prostate Cancer

Who this might be right for
Healthy Male SubjectsSuspected Prostate Cancer
Yunhe Pharmaceutical (Tianjin) Co., Ltd 32
Early research (Phase 1)Study completedNCT00030277
What this trial is testing

High-Intensity Focused Ultrasound in Treating Patients With Locally Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Focus Surgery 20
Testing effectiveness (Phase 2)Study completedNCT01882985
What this trial is testing

Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+3 more
University of California, Irvine 14
Testing effectiveness (Phase 2)Looking for participantsNCT07255664
What this trial is testing

A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC

Who this might be right for
Metastatic Colorectal CancerProstate Cancer MetastaticProstate Cancer Locally Advanced
Curacell Holding AB 12
Testing effectiveness (Phase 2)Study completedNCT00450411
What this trial is testing

Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 100
Early research (Phase 1)Study completedNCT00305669
What this trial is testing

GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 24
Early research (Phase 1)Study completedNCT00099086
What this trial is testing

Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Medical University of South Carolina 20
Large-scale testing (Phase 3)Study completedNCT00769548
What this trial is testing

Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,322
Large-scale testing (Phase 3)Study completedNCT00055731
What this trial is testing

Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse

Who this might be right for
Prostate Cancer
UNICANCER 413
Very early researchLooking for participantsNCT05852041
What this trial is testing

RhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage IIA Prostate Cancer AJCC v8+1 more
Northwestern University 40
Large-scale testing (Phase 3)Study completedNCT00765479
What this trial is testing

Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
University of Illinois at Chicago 284
Testing effectiveness (Phase 2)Ended earlyNCT05633160
What this trial is testing

64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT)

Who this might be right for
Prostatic NeoplasmsCastration-Resistant
Clarity Pharmaceuticals Ltd 4
Early research (Phase 1)Study completedNCT02119858
What this trial is testing

Diffuse Optical Imaging With Indocyanine Green Solution in Imaging Pelvic Lymph Nodes in Patients With Stage II Prostate Cancer Undergoing Surgery

Who this might be right for
Stage IIA Prostate CancerStage IIB Prostate Cancer
City of Hope Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT00528866
What this trial is testing

Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 80
Not applicableStudy completedNCT00003903
What this trial is testing

Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer

Who this might be right for
OsteoporosisProstate Cancer
University of Rochester 150
Load More Results